Why the study?
Do clinical classification schemes, specifically the CHADS2 index, accurately quantify the risk of stroke in patients with atrial fibrillation?
Population
Patients who have AF (atrial fibrillation)
Design
Cohort
Authors
Loading...
CHADS2 may aid AF stroke risk stratification; extends prior schemes but leaves open need for prospective validation.
Do clinical classification schemes, specifically the CHADS2 index, accurately quantify the risk of stroke in patients with atrial fibrillation?
The CHADS2 score is a valid tool for quantifying stroke risk in patients with atrial fibrillation, aiding in the selection of appropriate antithrombotic therapy.
Gage et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: